Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ciba Specialty Chemicals was a leading global manufacturer of specialty chemicals, headquartered in Basel, Switzerland. Spun off from Ciba-Geigy in 1997 following the merger that created Novartis, the company provided high-value chemical effects for products in sectors including healthcare, plastics, coatings, and water treatment. In the life sciences arena, Ciba was a significant supplier of pharmaceutical intermediates, antimicrobial agents, and specialized additives for medical devices and personal care products. The company was acquired by BASF in 2009, which integrated Ciba's extensive portfolio into its performance products and functional solutions divisions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ciba Specialty Chemicals.